Chronic superficial gastritis
Conditions
Interventions
Experimental group:Protect gastric mucosa powder
The cnotrol group:Positive control for the same effect
Sponsors
Affiliated Hospital of Jiangnan University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Admission criteria: Voluntary subjects meeting the diagnostic criteria for chronic superficial gastritis and confirmed by gastroscopic screening for gastric mucosal injury, aged 18-65 years. The diagnostic criteria of chronic superficial gastritis: the course of the disease is prolonged, with varying degrees of dyspepsia, epigastric pain, heartburn, belching, acid reflux, abdominal distension and other clinical symptoms, and may have mild epigastric tenderness. It conforms to the diagnosis criteria of chronic superficial gastritis by fibergastroscopy and biopsy.
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactation women, allergic constitution and allergic to this sample. 2. Secondary chronic gastritis. 3. Patients with serious diseases of cardiovascular, cerebrovascular, liver, kidney and hematopoietic system. 4. Frequent drug use, alcohol addiction, smoking, participated in other experiments within 4 weeks. 5. Used drugs known to impair gastrointestinal function within 3 months. 6. The symptoms and signs are classified as severe. 7. Patients with severe ulcer of digestive system. 8. Are taking other drugs or receiving other treatments. 9. Persons who fail to take samples according to the regulations and cannot judge the efficacy, or incomplete data affect the efficacy or safety judgment. With other types of immune system diseases (systemic lupus erythematosus, Graves' disease, psoriasis, etc.); 10. For women, those who are pregnant, breast-feeding, or hoping to become pregnant. 11. However, those who are currently or recently (within one month) carrying out other clinical studies. 12. Qiu was unwilling or unable to provide written informed consent for participation in the study after the researcher informed the researcher of the purpose, process and possible risks.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptom severity scale;Physical signs observation score sheet;short form 36 questionnaire;gastroscopy; | — |
Countries
China
Contacts
Public ContactFeng Zhang
Affiliated Hospital of Jiangnan University
Outcome results
None listed